Commonwealth Equity Services’s Acceleron Pharma XLRN Stock Holding History

Commonwealth Equity Services’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,349	Closed	-$232K	–	3796
2021 Q3	$232K	Buy	+1,349	New	+$176K	﹤0.01%	3152
2018 Q4	–	Sell	-3,545	Closed	-$202K	–	2849
2018 Q3	$202K	Buy	+3,545	New	+$174K	﹤0.01%	2503

Commonwealth Equity Services's XLRN Position: Q4 2021 in Review

Commonwealth Equity Services sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,349 shares — an estimated $232K sold.

Commonwealth Equity Services first reported a position in XLRN in Q3 2018 and held it in 2 quarters. The position peaked at $232K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Commonwealth Equity Services reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Commonwealth Equity Services sold 1,349 Acceleron Pharma shares in Q4 2021, an estimated $232K.
Commonwealth Equity Services first reported a position in Acceleron Pharma in Q3 2018 and held it in 2 quarters.
Commonwealth Equity Services's Acceleron Pharma position peaked at $232K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.